Since 2012, Denis Horgan (PHD) is the Executive Director of the European Alliance for Personalised Medicine (EAPM).
The Alliance brings together European healthcare experts and patient advocates involved with major chronic diseases, with the aim of improving healthcare by accelerating the development, delivery and uptake of personalised medicine and diagnostics, through consensus.
The mix of EAPM members provides extensive scientific, clinical, caring and training expertise in personalised medicine and diagnostics, across patient groups, academia, health professionals and industry. Relevant departments of the European Commission have observer status, as does your own organisation, of course. In the relatively short time since it was formed, EAPM has been in the vanguard of raising the profile and explaining the possibilities of personalised medicine in Europe. This is not only among MEPs and European Commission officials, but also among stakeholders across the health arena as well as the general public.
Prior to setting up EAPM, Denis worked as the Brussels Director of the European Cancer Patient Coalition from 2009. The European Cancer Patient Coalition (ECPC) is the voice of cancer patients in Europe. With over 400 members, ECPC is Europe’s largest umbrella cancer patents’ association, covering all 28 EU member states and many other European and non-European countries. ECPC represents patients affected by all types of cancers, from the rarest to the most common.
In recent years, through his efforts, this has created an observable institutional shift in policy due to the issues that the Alliance has put forward through its multi-stakeholder membership and bottom-up policy making. EAPM maintains that, given the outmodedness of a one-size-fits-all mentality in which doctors treat by population averages rather than by the individual (including his or her lifestyle choic-es), the personalised medicine approach is the best way forward.